These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36581220)

  • 21. Defining the combinatorial space of PKC::CARD-CC signal transduction nodes.
    Staal J; Driege Y; Haegman M; Kreike M; Iliaki S; Vanneste D; Lork M; Afonina IS; Braun H; Beyaert R
    FEBS J; 2021 Mar; 288(5):1630-1647. PubMed ID: 32790937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.
    Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D
    Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
    Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
    J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
    Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
    J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro reconstitution of interactions in the CARD9 signalosome.
    Park JH; Choi JY; Mustafa MF; Park HH
    Mol Med Rep; 2017 Oct; 16(4):3910-3916. PubMed ID: 28765954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family.
    Staal J; Driege Y; Van Gaever F; Steels J; Beyaert R
    FEBS J; 2024 Mar; 291(6):1220-1245. PubMed ID: 38098267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.
    Cheng J; Maurer LM; Kang H; Lucas PC; McAllister-Lucas LM
    Cell Immunol; 2020 Sep; 355():104158. PubMed ID: 32721634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular architecture and regulation of BCL10-MALT1 filaments.
    Schlauderer F; Seeholzer T; Desfosses A; Gehring T; Strauss M; Hopfner KP; Gutsche I; Krappmann D; Lammens K
    Nat Commun; 2018 Oct; 9(1):4041. PubMed ID: 30279415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
    McCully RR; Pomerantz JL
    Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
    Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
    J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation.
    Werninghaus K; Babiak A; Gross O; Hölscher C; Dietrich H; Agger EM; Mages J; Mocsai A; Schoenen H; Finger K; Nimmerjahn F; Brown GD; Kirschning C; Heit A; Andersen P; Wagner H; Ruland J; Lang R
    J Exp Med; 2009 Jan; 206(1):89-97. PubMed ID: 19139169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
    Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
    J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.
    Rosenbaum M; Gewies A; Pechloff K; Heuser C; Engleitner T; Gehring T; Hartjes L; Krebs S; Krappmann D; Kriegsmann M; Weichert W; Rad R; Kurts C; Ruland J
    Nat Commun; 2019 May; 10(1):2352. PubMed ID: 31138793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nucleation barrier spring-loads the CBM signalosome for binary activation.
    Rodriguez Gama A; Miller T; Lange JJ; Unruh JR; Halfmann R
    Elife; 2022 Jun; 11():. PubMed ID: 35727133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
    Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
    Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
    Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting BCL10 by small peptides for the treatment of B cell lymphoma.
    Bao W; Sun C; Sun X; He M; Yu H; Yan W; Wen F; Zhang L; Yang C
    Theranostics; 2020; 10(25):11622-11636. PubMed ID: 33052237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.